Sunday, May 30, 2021

People Want an Alzheimer’s Drug. Aducanumab Isn’t the One.

An F.D.A. sign-off for aducanumab would make finding a good treatment harder.

from NYT > Top Stories https://ift.tt/34psXgz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Oscars Will Move to a Venue Outside Hollywood

The event will be held in downtown Los Angeles starting in 2029 as part of a deal between the academy and AEG, a developer of entertainment ...